Currently, studies examining the correlation between SHP2 or STAT3 with CRC prognosis have been reported18,36,37, but no study clearly established the association between the combination of SHP2/nuclear STAT3 status and the outcomes of patients with CRC. This evidence concerns the gene PTPN11 and colorectal carcinoma.